Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

FDA Approves Summit's Ophthalmic Excimer Laser

Photonics Spectra
Mar 1997
The US Food and Drug Administration (FDA) recently gave Summit Technology Inc. of Waltham, Mass., approval to market the SVS Apex Plus excimer laser system for the treatment of mild to moderate nearsightedness, corneal scars and disorders, and dystrophies. The company says Apex systems can be upgraded to the Plus version in three days. Summit is seeking FDA approval to use Apex Plus for astigmatism and hyperopia.

As We Go To PressBreaking NewslasersPresstime Bulletin

Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media
x Subscribe to Photonics Spectra magazine - FREE!